Bank of New York Mellon Corp Has $657.69 Million Position in Mettler-Toledo International Inc. (NYSE:MTD)

Bank of New York Mellon Corp lessened its stake in Mettler-Toledo International Inc. (NYSE:MTDFree Report) by 1.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 537,468 shares of the medical instruments supplier’s stock after selling 10,648 shares during the period. Bank of New York Mellon Corp owned about 2.55% of Mettler-Toledo International worth $657,688,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Blue Trust Inc. lifted its position in shares of Mettler-Toledo International by 242.9% in the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after acquiring an additional 17 shares during the period. Ashton Thomas Securities LLC acquired a new position in shares of Mettler-Toledo International in the third quarter valued at $37,000. Sound Income Strategies LLC raised its stake in shares of Mettler-Toledo International by 4,500.0% in the fourth quarter. Sound Income Strategies LLC now owns 46 shares of the medical instruments supplier’s stock valued at $56,000 after purchasing an additional 45 shares in the last quarter. Huntington National Bank lifted its position in Mettler-Toledo International by 20.0% in the third quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock worth $81,000 after purchasing an additional 9 shares during the period. Finally, Itau Unibanco Holding S.A. boosted its stake in Mettler-Toledo International by 80.0% during the third quarter. Itau Unibanco Holding S.A. now owns 54 shares of the medical instruments supplier’s stock worth $81,000 after buying an additional 24 shares in the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of the firm’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the sale, the insider now owns 6 shares in the company, valued at approximately $8,108.04. This trade represents a 99.01 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Trading Up 0.0 %

NYSE:MTD opened at $1,310.50 on Wednesday. The stock has a market capitalization of $27.42 billion, a P/E ratio of 32.33, a price-to-earnings-growth ratio of 3.30 and a beta of 1.13. Mettler-Toledo International Inc. has a 1 year low of $1,142.91 and a 1 year high of $1,546.93. The firm has a 50 day moving average of $1,287.86 and a 200-day moving average of $1,331.78.

Mettler-Toledo International (NYSE:MTDGet Free Report) last issued its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. As a group, analysts forecast that Mettler-Toledo International Inc. will post 42.71 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on MTD. Wells Fargo & Company increased their price objective on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research note on Monday, February 10th. Stifel Nicolaus dropped their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Evercore ISI raised their price target on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a research note on Monday, February 10th. Wolfe Research began coverage on Mettler-Toledo International in a research note on Friday, December 13th. They issued a “peer perform” rating on the stock. Finally, Robert W. Baird raised their target price on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $1,368.00.

Get Our Latest Stock Report on MTD

About Mettler-Toledo International

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Read More

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTDFree Report).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.